The Royal Marsden Cancer Charity hails Sheikha Jawaher Al Qasimi’s role in advancing precision medicine for cancer treatment

The Sharjah Clinical Genomics Laboratory in the UK is advancing research and bringing hope to thousands of cancer patients

  • A humanitarian initiative by HH Sheikha Jawaher Al Qasimi, the lab was established with a £500,000 donation
  • One of only two UK labs selected by NHS England to evaluate long-read whole genome sequencing for clinical application.
  • Enhancing lung cancer genetic mutation analysis using ‘Liquid Biopsy’ technology
  • Capacity has been doubled to deliver an additional ,000 genetic tests monthly
  • Actively participating in clinical trials for DNA-based personalised therapies
  • The Royal Marsden is a specialist cancer centre that brings together world class researchers and dedicated clinical teams providing expert compassionate care

Sharjah, August 11, 2025,

The Royal Marsden Cancer Charity; which supports the work of The Royal Marsden; has commended the significant support of Her Highness Sheikha Jawaher bint Mohammed Al Qasimi, Wife of the Ruler of Sharjah and Founder/Royal Patron of the Friends of Cancer Patients (FoCP). Its annual report highlighted her contributions to advancing cancer research, particularly through initiatives over the past five years that have accelerated progress at the Sharjah Clinical Genomics Laboratory within the National Institute for Health and Care Research (NIHR) Centre for Molecular Pathology (CMP);  housed within The Royal Marsden in the UK. These efforts have greatly enhanced faster delivery of precise diagnoses and cutting-edge personalised treatments for patients.

The report underscored that Her Highness’s support has empowered the lab’s scientific team to fast-track diagnostics and treatments, bringing hope to thousands of patients. This was achieved through the introduction of state-of-the art facilities to the Sharjah Clinical Genomics Laboratory; including the UK’s first robotic genome testing facility; and bringing together world experts in molecular pathology, bioinformatics, translational research.

Continue reading The Royal Marsden Cancer Charity hails Sheikha Jawaher Al Qasimi’s role in advancing precision medicine for cancer treatment

Eyestem Raises Funds to Advance Eyecyte-RPE™ Through Phase 2 Clinical Trial and Towards US IND

India, 11th August 2025: Eyestem Research Pvt Ltd has raised funds in a significantly oversubscribed funding round to support the next stage of development for its investigational retinal pigment epithelial (RPE) cell therapy, Eyecyte-RPE™.

The capital will enable completion of the ongoing Phase 2 clinical trial in India and support preparations for filing an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA).

“Strong participation by internal investors and addition of a strategic investor, underline the shared belief in Eyestem’s long-term vision of creating an innovative cell therapy platform providing scalable solutions for incurable diseases worldwide. This  $10 million fundraise will support the next leg of development and strengthen the foundation for global expansion. We continue to prioritize rigorous clinical progress and the capabilities needed to ensure global patient access to this therapy,” said Dr. Jogin Desai, Founder and CEO, Eyestem.

(L to R) Dr Jogin Desai, Dr Rajani Battu & Dr Rajarshi Pal

Continue reading Eyestem Raises Funds to Advance Eyecyte-RPE™ Through Phase 2 Clinical Trial and Towards US IND

Axis Communications Announces Two Multifunctional Display Speakers

Dubai, United Arab Emirates August 2025:Axis Communications announces two multifunctional display speakers designed to reach more people through combined visual and audio alerts. Featuring an attention-grabbing strobe bar, powerful speaker, and a colour text display, these versatile indoor solutions raise the bar for clear public address in schools, healthcare facilities, transportation hubs, and more.  

AXIS C1710 Network Display Speaker and the dual-sided corridor model, AXIS C1720 Network Display Speaker, are suited for general public address as well as urgent messaging. Built on open standards, AXIS C17 Series integrates with third-party mass notification systems to ensure effective communication when it matters most.  

Continue reading Axis Communications Announces Two Multifunctional Display Speakers

Baker Tilly International Expands Regional Presence with Launch of New UAE Network Firm Led by New CEO

The globally recognised accountancy network establishes its UAE operations with a future-focused mandate across audit, tax, and consultancy under visionary leadership of the new CEO.

Dubai, UAE, August 10, 2025: Baker Tilly International, a top 10 global network of accounting and advisory firms with presence in over 140 countries and with over 43,000 people, has announced the official launch of its new member firm in the United Arab Emirates. Headquartered in Dubai and led by newly appointed CEO and Managing Partner Saad Maniar, the UAE firm strengthens the network’s presence in one of the region’s most strategically important markets.

Saad Maniar, CEO and Managing Partner of Baker Tilly in the UAE,

Continue reading Baker Tilly International Expands Regional Presence with Launch of New UAE Network Firm Led by New CEO

Years of pain, one breakthrough: Emirati man spared lifetime of incontinence after UAE’s first endoscopic rectal tumour removal

38-year-Old Emirati man suffering for years with pain and bleeding gets groundbreaking procedure 

Dubai – August 11, 2025:Medcare Royal Specialty Hospital has achieved a global medical milestone, successfully performing the first-ever full-thickness endoscopic rectal tumor removal followed by advanced endoscopic hand suturing. This ultra-complex procedure, carried out by Dr. Mohamed Abdelhafez, Head of the Gastroenterology and Endoscopy, Advanced Endoscopy Department at Medcare Royal Specialty Hospital and Associate Professor of Gastroenterology at the Technical University of Munich, Germany, showcases a level of expertise and technology only available in highly specialized centers worldwide.

The 38-year-old Emirati patient had endured years of pain, rectal bleeding, and chronic constipation caused by Solitary Rectal Ulcer Syndrome (SRUS). Traditionally, such a condition would have required invasive open surgery with a high risk of permanent incontinence. Instead, Dr. Abdelhafez performed a full-thickness Endoscopic Submucosal Dissection (ESD) to completely remove the ulcerated tumor located dangerously close to the anal sphincter. He then closed the large post-resection defect using the cutting-edge SutuArt endoscopic hand suturing system, ensuring optimal healing while preserving full muscle control.

Continue reading Years of pain, one breakthrough: Emirati man spared lifetime of incontinence after UAE’s first endoscopic rectal tumour removal